{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:11:25Z","timestamp":1776787885944,"version":"3.51.2"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,7]]},"DOI":"10.18632\/oncotarget.8989","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T09:24:46Z","timestamp":1461662686000},"page":"34832-34844","source":"Crossref","is-referenced-by-count":28,"title":["Metformin blocks progression of obesity-activated thyroid cancer in a mouse model"],"prefix":"10.18632","volume":"7","author":[{"given":"Jeongwon","family":"Park","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Gu","family":"Kim","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"},{"name":"Current Address: Division of Endocrinology, Department of Internal Medicine Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, South Korea, Seoul 138-736"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Enomoto","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Willingham","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheue-Yann","family":"Cheng","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clon.2010.05.004","article-title":"Thyroid cancer epidemiology and prognostic variables","volume":"22","author":"Mazzaferri","year":"2010","journal-title":"Clinical oncology"},{"key":"2","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Forman","year":"2011","journal-title":"CA"},{"key":"3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/thy.2010.0396","article-title":"Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study","volume":"21","author":"Ward","year":"2011","journal-title":"Thyroid"},{"key":"4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1158\/1055-9965.EPI-10-1220","article-title":"Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies","volume":"20","author":"Berrington de Gonzalez","year":"2011","journal-title":"Cancer epidemiology, biomarkers & prevention"},{"key":"5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/thy.2013.0232","article-title":"Obesity and thyroid cancer: a clinical update","volume":"24","author":"Alevizaki","year":"2014","journal-title":"Thyroid"},{"key":"6","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1177\/030006051204000601","article-title":"Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies","volume":"40","author":"Cao","year":"2012","journal-title":"The Journal of international medical research"},{"key":"7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2265.2012.04506.x","article-title":"Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer","volume":"78","author":"Kim","year":"2013","journal-title":"Clinical endocrinology"},{"key":"8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/onc.2008.407","article-title":"PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer","volume":"28","author":"Cheng","year":"2009","journal-title":"Oncogene"},{"key":"9","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1210\/en.2013-1128","article-title":"Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model","volume":"154","author":"Cheng","year":"2013","journal-title":"Endocrinology"},{"key":"10","first-page":"53","article-title":"Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model","volume":"23","author":"Cheng","year":"2016","journal-title":"Endocrine-related cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/onc.2012.181","article-title":"Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects","volume":"32","author":"Pilotti","year":"2013","journal-title":"Oncogene"},{"key":"12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ncpendmet0843","article-title":"The prevention of type 2 diabetes","volume":"4","author":"Diabetes Prevention Program Research","year":"2008","journal-title":"Nature clinical practice Endocrinology & metabolism"},{"key":"13","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Yee","year":"2010","journal-title":"Diabetes care"},{"key":"14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.18632\/aging.100561","article-title":"Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer","volume":"5","author":"Anisimov","year":"2013","journal-title":"Aging (Albany, NY)"},{"key":"15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.18632\/aging.100556","article-title":"Metformin, aging and cancer","volume":"5","author":"Ferbeyre","year":"2013","journal-title":"Aging (Albany, NY)"},{"key":"16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.18632\/aging.100455","article-title":"Metformin in obesity, cancer and aging: addressing controversies","volume":"4","author":"Berstein","year":"2012","journal-title":"Aging (Albany, NY)"},{"key":"17","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.4161\/15384101.2014.970491","article-title":"Comparison of rapamycin schedules in mice on high-fat diet","volume":"13","author":"Blagosklonny","year":"2014","journal-title":"Cell Cycle"},{"key":"18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/acel.12211","article-title":"Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet","volume":"13","author":"Blagosklonny","year":"2014","journal-title":"Aging cell"},{"key":"19","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.18632\/aging.890","article-title":"Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions","volume":"3","author":"Blagosklonny","year":"2012","journal-title":"Oncotarget"},{"key":"20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF03345423","article-title":"Does use of metformin protect against cancer in Type 2 diabetes mellitus?","volume":"35","author":"Ghigo","year":"2012","journal-title":"Journal of endocrinological investigation"},{"key":"21","doi-asserted-by":"crossref","first-page":"e71583","DOI":"10.1371\/journal.pone.0071583","article-title":"Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review","volume":"8","author":"Nicolucci","year":"2013","journal-title":"PloS one"},{"key":"22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1186\/s12885-015-1719-6","article-title":"No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study","volume":"15","author":"Bodmer","year":"2015","journal-title":"BMC cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/1055-9965.EPI-10-0817","article-title":"Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark","volume":"20","author":"Lash","year":"2011","journal-title":"Cancer epidemiology, biomarkers & prevention"},{"key":"24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1478-3231.2010.02223.x","article-title":"Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease","volume":"30","author":"Zanette","year":"2010","journal-title":"Liver international"},{"key":"25","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1210\/jc.2012-3799","article-title":"Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer","volume":"98","author":"Vasko","year":"2013","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"26","doi-asserted-by":"crossref","first-page":"E510","DOI":"10.1210\/jc.2011-1754","article-title":"Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents","volume":"97","author":"Derwahl","year":"2012","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/ERC-12-0046","article-title":"Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells","volume":"19","author":"Vasko","year":"2012","journal-title":"Endocrine-related cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"e53176","DOI":"10.1371\/journal.pone.0053176","article-title":"Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK\/STAT, PI3K\/Akt and MEK\/ERK pathways","volume":"7","author":"Liu","year":"2012","journal-title":"PloS one"},{"key":"29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.onc.1207003","article-title":"Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89","volume":"23","author":"Zehner","year":"2004","journal-title":"Oncogene"},{"key":"30","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1074\/jbc.M111.295964","article-title":"Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition","volume":"287","author":"Fang","year":"2012","journal-title":"The Journal of biological chemistry"},{"key":"31","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1158\/0008-5472.CAN-14-2842","article-title":"Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function","volume":"75","author":"Soini","year":"2015","journal-title":"Cancer research"},{"key":"32","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jmb.2006.09.056","article-title":"Vimentin binding to phosphorylated Erk sterically hinders enzymatic dephosphorylation of the kinase","volume":"364","author":"Fainzilber","year":"2006","journal-title":"Journal of molecular biology"},{"key":"33","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1242\/jcs.00059","article-title":"Fibronectin at a glance","volume":"115","author":"Yamada","year":"2002","journal-title":"Journal of cell science"},{"key":"34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities","volume":"5","author":"Guan","year":"2015","journal-title":"Acta pharmaceutica Sinica B"},{"key":"35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/icb.2014.22","article-title":"Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion","volume":"92","author":"Rosendahl","year":"2014","journal-title":"Immunology and cell biology"},{"key":"36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000437365","article-title":"Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid Cancer","volume":"4","author":"Kim","year":"2015","journal-title":"European thyroid journal"},{"key":"37","first-page":"189","article-title":"Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment","volume":"4","author":"Nucera","year":"2013","journal-title":"Frontiers in endocrinology"},{"key":"38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4174\/jkss.2011.81.5.308","article-title":"A missense polymorphism (rs11895564, Ala380Thr) of integrin alpha 6 is associated with the development and progression of papillary thyroid carcinoma in Korean population","volume":"81","author":"Kim","year":"2011","journal-title":"Journal of the Korean Surgical Society"},{"key":"39","doi-asserted-by":"crossref","first-page":"e100562","DOI":"10.1371\/journal.pone.0100562","article-title":"Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation","volume":"9","author":"Moustafa","year":"2014","journal-title":"PloS one"},{"key":"40","doi-asserted-by":"publisher","first-page":"44579","DOI":"10.18632\/oncotarget.6373","article-title":"Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2\/HIF-1alpha\/VEGF secretion axis","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"41","doi-asserted-by":"crossref","first-page":"E534","DOI":"10.1002\/ijc.29193","article-title":"The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells","volume":"136","author":"Bertolini","year":"2015","journal-title":"International journal of cancer"},{"key":"42","first-page":"592523","article-title":"Attenuating tumour angiogenesis: a preventive role of metformin against breast cancer","volume":"2015","author":"Kong","year":"2015","journal-title":"BioMed research international"},{"key":"43","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Cantley","year":"2005","journal-title":"Science"},{"key":"44","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Moller","year":"2001","journal-title":"The Journal of clinical investigation"},{"key":"45","article-title":"Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer","author":"Chhipa","year":"2015","journal-title":"Trends in pharmacological sciences"},{"key":"46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","article-title":"Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways","volume":"14","author":"Manning","year":"2011","journal-title":"Cell metabolism"},{"key":"47","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","article-title":"Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth","volume":"67","author":"Thompson","year":"2007","journal-title":"Cancer research"},{"key":"48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13110","article-title":"Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides","volume":"508","author":"Sabatini","year":"2014","journal-title":"Nature"},{"key":"49","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1089\/105072502320908295","article-title":"Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis","volume":"12","author":"Cheng","year":"2002","journal-title":"Thyroid"},{"key":"50","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neo.2014.08.003","article-title":"Synergistic signaling of KRAS and thyroid hormone receptor beta mutants promotes undifferentiated thyroid cancer through MYC up-regulation","volume":"16","author":"Cheng","year":"2014","journal-title":"Neoplasia"},{"key":"51","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1210\/en.2013-1028","article-title":"Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer","volume":"154","author":"Damante","year":"2013","journal-title":"Endocrinology"},{"key":"52","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1038\/onc.2010.308","article-title":"Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females","volume":"29","author":"Di Cristofano","year":"2010","journal-title":"Oncogene"},{"key":"53","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1172\/JCI46382","article-title":"Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation","volume":"121","author":"Fagin","year":"2011","journal-title":"The Journal of clinical investigation"},{"key":"54","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1073\/pnas.1015557108","article-title":"Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice","volume":"108","author":"Fagin","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"55","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4161\/cc.9.1.10407","article-title":"Metformin extends life span of HER-2\/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo","volume":"9","author":"Romanyukha","year":"2010","journal-title":"Cell cycle"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T20:49:19Z","timestamp":1589230159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,26]]},"references-count":55,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2016,6,7]]}},"alternative-id":["8989","27145454"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8989","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,26]]}}}